Proliferative Vitreoretinopathy Clinical Trial
Official title:
Determining the Effect of Low-dose Isotretinoin on Proliferative Vitreoretinopathy
Proliferative vitreoretinopathy (PVR), or secondary scarring on and around the retina, is an important cause of retinal re-detachment. The purpose of this study is to evaluate the effect of oral isotretinoin, which inhibits the growth of cells responsible for proliferative vitreoretinopathy (PVR), on recurrent retinal detachment.
Small retrospective studies have shown isotretinoin to be effective in reducing the rate of recurrent retinal detachment in patients with or at high risk for developing PVR. This is a prospective study to evaluate a low dose of oral isotretinoin in this regard. There are two arms to the study: 1) eyes with recurrent retinal detachment due to existing PVR, and 2) eyes with primary detachment and features associated with a high risk of PVR formation. Eligible and willing patients will receive a 12-week course of isotretinoin, and will be followed for retinal attachment rate, and PVR and/or ERM (epiretinal membrane) formation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05561569 -
Air Versus Gas Tamponade in Primary Retinal Detachment
|
N/A | |
| Not yet recruiting |
NCT05538156 -
Internal Limiting Membrane Peeling in Retinal Detachment Surgery
|
N/A | |
| Recruiting |
NCT00370760 -
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
|
Phase 3 | |
| Completed |
NCT00000140 -
The Silicone Study
|
Phase 3 | |
| Completed |
NCT06166914 -
Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
|
N/A | |
| Recruiting |
NCT04580147 -
Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
|
Phase 2 | |
| Completed |
NCT04891991 -
Intravitreal Infliximab for Proliferative Vitreoretinopathy
|
Phase 2 | |
| Completed |
NCT01255293 -
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
|
N/A | |
| Completed |
NCT04136366 -
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
|
Phase 3 | |
| Recruiting |
NCT06289205 -
"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"
|
Phase 1/Phase 2 | |
| Completed |
NCT00373282 -
Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy
|
Phase 3 | |
| Completed |
NCT01995045 -
Postoperative Pain Control Following Vitreoretinal Surgery
|
Phase 4 | |
| Completed |
NCT04490876 -
Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoretinopathy
|
||
| Completed |
NCT02192970 -
Bevacizumab Against Recurrent Retinal Detachment
|
Phase 2 | |
| Not yet recruiting |
NCT04682054 -
Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics
|
N/A | |
| Recruiting |
NCT05660447 -
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06033703 -
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00371020 -
The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
|
Phase 3 | |
| Completed |
NCT03727776 -
Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
|
Early Phase 1 | |
| Recruiting |
NCT04482543 -
Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C
|
Phase 2/Phase 3 |